Ichor Announces Participation in Upcoming Investor Conferences

FREMONT, Calif.--(BUSINESS WIRE)-- Ichor Holdings, Ltd. (NASDAQ: ICHR), a leader in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment, today announced management’s participation in the following investor events taking place during the third quarter:

Oppenheimer Virtual Technology, Internet & Communications Conference
August 11, 2025

Needham Virtual Semiconductor & SemiCap 1x1 Conference
August 20, 2025

Jefferies Semiconductor, IT Hardware & Communications Technology Conference
Four Seasons Chicago
August 26, 2025

B. Riley Securities Annual Consumer & TMT Conference
Sofitel New York City
September 10, 2025

The presentation material utilized during these conferences will be made accessible on the investor page of the company’s website at https://ir.ichorsystems.com.

About Ichor

We are a leader in the design, engineering and manufacturing of critical fluid delivery subsystems and components primarily for semiconductor capital equipment, as well as other industries such as defense/aerospace and medical. Our primary product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. Our gas delivery subsystems deliver, monitor and control precise quantities of the specialized gases used in semiconductor manufacturing processes such as etch and deposition. Our chemical delivery subsystems precisely blend and dispense the reactive liquid chemistries used in semiconductor manufacturing processes such as chemical-mechanical planarization, electroplating, and cleaning. We also provide precision-machined components, weldments, e-beam and laser welded components, precision vacuum and hydrogen brazing, surface treatment technologies, and other proprietary products. We are headquartered in Fremont, CA.

https://ir.ichorsystems.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20250805836464/en/

Greg Swyt, CFO 510-897-5200
Claire McAdams, IR & Strategic Initiatives 530-265-9899
[email protected]

Source: Ichor Holdings, Ltd.

You May Also Be Interested In

• Access Advance Launches Exploration Phase for an AV1/AV2 Device and Software Patent Pool, Invites Participation of Potential Licensors
• Avetta Appoints Lynda Richards as APAC Principal, Health and Safety
• Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Durvalumab Plus Chemotherapy in First-Line Advanced Biliary Tract Cancer in Single-Region Tria